Godavari Biorefineries Limited — Updates, 11-11-2025: Press Release

Godavari Biorefineries announced Q2 results showing recovery. Total income was Rs 434.3 Cr; EBITDA loss narrowed significantly to Rs (4.4) Cr. Bio-based chemicals and Ethanol segment EBITDA grew. Company advanced anti-cancer drug trials, secured a patent, and launched a CO2-to-DME pilot. A Rs 26.7 Cr exceptional expense was booked.